Market
What will be cited as the primary reason for Louisiana's vaccine policy change by end of 2025?
2
Resolution / Starting Odds
Economic impact concerns • 25%
Political ideology • 25%
Public health strategy shift • 25%
Other reasons • 25%
Official statements or reports from the Louisiana Department of Health or the Governor's office
Story
Louisiana Bans Vaccine Promotion for COVID, Flu, and Mpox, Citing $100M-$300M Economic Impact
Dec 20, 2024, 05:48 PM
The Louisiana Department of Health has implemented a new policy that prohibits its public health workers from promoting vaccines for COVID-19, influenza, and mpox. According to NPR's investigation, this directive was communicated in meetings held in October and November 2024, with staff being instructed not to encourage the public to get these vaccines through any means, including press releases, interviews, events, presentations, or social media posts. The policy also prevents the department from displaying signs at its clinics indicating the availability of these vaccines. This shift in policy is part of a broader reevaluation of the state's public health priorities, moving away from what the department describes as 'one-size-fits-all paternalistic guidance' towards emphasizing individual choice in vaccination decisions. The change has raised concerns among health department employees about the potential impact on public health, with fears that it could lead to increased deaths from preventable diseases. The estimated annual economic impact on Louisiana due to lost productivity from flu alone is between $100M to $300M. This policy change follows the election of Gov. Jeff Landry, who has been critical of vaccine mandates.
View original story
Similar markets
Looser vaccine mandates • 25%
Other changes • 25%
No change • 25%
Stricter vaccine mandates • 25%
No change • 25%
Increase mandates • 25%
Decrease mandates • 25%
Complete removal of mandates • 25%
Mixed reactions • 25%
Widespread support • 25%
Predominantly negative • 25%
Major public protests • 25%
No significant response • 25%
Evenly split • 25%
Majority opposed • 25%
Majority supportive • 25%
Increased CDC funding • 25%
No significant changes • 25%
Other • 25%
New health partnerships • 25%
Increase in support • 25%
Decrease in support • 25%
No change • 25%
Mixed opinions • 25%
Public opinion divided • 25%
Majority support changes • 25%
Majority oppose changes • 25%
Insufficient data • 25%
Other • 25%
Vaccine hesitancy • 25%
Waning vaccine protection • 25%
Lack of access to healthcare • 25%
Emergency powers enacted • 25%
New security measures implemented • 25%
Increased funding for counter-terrorism • 25%
No significant policy changes • 25%
Neutral • 25%
Supportive • 25%
Critical • 25%
No significant response • 25%
Decreased support for protections • 25%
Other • 25%
No significant change • 25%
Increased support for protections • 25%